Tower Research Capital LLC (Trc) Ultragenyx Pharmaceutical Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,965 shares of RARE stock, worth $65,002. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,965
Previous 1,460
34.59%
Holding current value
$65,002
Previous $53,000
11.32%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding RARE
# of Institutions
348Shares Held
88.2MCall Options Held
2.19MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10.1MShares$335 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$185 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY4.01MShares$133 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.77MShares$125 Million0.33% of portfolio
-
State Street Corp Boston, MA3.69MShares$122 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.32B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...